Last reviewed · How we verify
NCT07162493: AiD
ATTACH in Denmark: A Feasibility Randomized Controlled Trial
NA trial testing ATTACH in Mentalization in 52 participants. Currently enrolling.
31 May 2027
Quick facts
| Lead sponsor | Johanne Smith-Nielsen |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 52 |
| Start date | 1 September 2025 |
| Primary completion | 31 May 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 3 locations across Denmark |
Drugs / interventions tested
- ATTACH
- Treatment as Usual (TAU) — full drug profile →
Conditions studied
- Mentalization — all drugs for Mentalization →
- Recruitment of Participants — all drugs for Recruitment of Participants →
- Adherence, Treatment — all drugs for Adherence, Treatment →
- Drop Out — all drugs for Drop Out →
Sponsor
Johanne Smith-Nielsen
Who can join
18 and older, any sex, with Mentalization or Recruitment of Participants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this feasibility randomized controlled pilot trial is to learn whether the trial can be done as planned, and to investigate if the 10-session parenting program "ATTACH(TM) increases mentalizing skills (the ability to reflect on thoughts and feelings) in parents of children between 0-5 years of age, who are receiving support for psychosocial problems in their municipal family treatment center. The main questions the trial aims to answer are: * How many eligible parents agree to participate in the random allocation to treatment? * How many parents allocated to receive "ATTACH(TM) will have completed the program 5 months after allocation (at least 7 out of 10 sessions)? * How many parents complete the data collection 5 months after allocation on the primary exploratory clinical outcome, i.e., parental mentalizing skills? * Do parents who received the ATTACH(TM) program show more increase in their mentalizing skills, compared to parents, who did not receive treatment with ATTACH(TM)? Researchers will compare ATTACH, added to Treatment as Usual, with Treatment as Usual without ATTACH in three municipal family treatment centers located in the Capital Region of Denmark. Participants will: 1. Take part in baseline data collection with a survey, video observation of parent-child interaction, and an interview assessing mentalizing skills. 2. Be randomly allocated to receive treatment in their local family center with or without ATTACH. 3. Take part in data collection 5 months after being allocated to either group, as well as participate in an interview about their experiences with the treatment they received. 4. After one year, the research group will follow up on the current treatment/support needs of the families, who were allocated to either group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07162493
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mentalization
Currently open trials in the same condition.
- NCT07249593 — Recognizing Children's Needs: Impact on Early Childhood Regulatory Problems · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07162493 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johanne Smith-Nielsen
- Last refreshed: 23 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07162493.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing